SS Innovations International (SSII) Return on Capital Employed (2017 - 2026)
SS Innovations International recorded quarterly Return on Capital Employed of 21.31% in Q1 2026, up 31.91% quarter-over-quarter from 31.29% in Q4 2025, and up 5407.0% year-over-year from 0.39% in Q1 2025.
SS Innovations International's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 21.31% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 5407.0% year-over-year to 21.31%; the TTM figure through Mar 2026 stood at 21.31% (up 5407.0% YoY), while the FY2025 annual figure was 25.56%, up 9593.0% from the prior year.
- Return on Capital Employed came in at 21.31% for Q1 2026 at SS Innovations International, up from 31.29% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 449.96% in Q3 2022 to a low of 1549.82% in Q2 2022.
- A 5-year average of 247.26% and a median of 94.91% in 2023 frame the typical range for Return on Capital Employed.
- On a YoY basis, Return on Capital Employed climbed as much as 163639 bps in 2022 and fell as far as 170483 bps in 2022.
- SS Innovations International's Return on Capital Employed stood at 61.07% in 2022, then tumbled by 255 bps to 94.91% in 2023, then tumbled by 77 bps to 167.74% in 2024, then jumped by 81 bps to 31.29% in 2025, then jumped by 32 bps to 21.31% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 21.31%, 31.29%, and 47.37% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | -21.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.31% |
| Dec 31, 2025 | -31.29% |
| Sep 30, 2025 | -47.37% |
| Jun 30, 2025 | -51.77% |
| Mar 31, 2025 | -75.37% |
| Dec 31, 2024 | -167.74% |
| Sep 30, 2024 | -155.46% |
| Jun 30, 2024 | -136.61% |
| Mar 31, 2024 | -142.85% |
| Dec 31, 2023 | -94.91% |
| Sep 30, 2023 | -76.25% |
| Jun 30, 2023 | -827.05% |
| Mar 31, 2023 | -280.50% |
| Dec 31, 2022 | 61.07% |
| Sep 30, 2022 | 449.96% |
| Jun 30, 2022 | -1,549.82% |
| Mar 31, 2022 | -1,056.09% |
| Dec 31, 2021 | -1,575.32% |
| Sep 30, 2021 | 152.17% |
| Jun 30, 2021 | 155.02% |
| Mar 31, 2021 | 133.95% |
| Dec 31, 2020 | 112.12% |
| Sep 30, 2020 | 148.95% |
| Jun 30, 2020 | 248.52% |
| Mar 31, 2020 | 307.86% |
| Dec 31, 2019 | 325.06% |
| Sep 30, 2019 | 291.11% |
| Jun 30, 2019 | 206.79% |
| Mar 31, 2019 | 238.49% |
| Dec 31, 2018 | 512.04% |
| Sep 30, 2018 | 528.27% |
| Jun 30, 2018 | -3,715.01% |
| Mar 31, 2018 | -494.64% |
| Dec 31, 2017 | -771.83% |
| Sep 30, 2017 | -391.20% |